Viewing Study NCT03556592


Ignite Creation Date: 2025-12-24 @ 3:55 PM
Ignite Modification Date: 2026-01-26 @ 8:21 PM
Study NCT ID: NCT03556592
Status: COMPLETED
Last Update Posted: 2025-02-24
First Post: 2018-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
Sponsor: LEO Pharma
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords: